| Q59389571 | AgNOR count as objective marker for dysplastic features in oral leukoplakia |
| Q42459288 | Altered expression of alpha 6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions |
| Q42119241 | Between-lesion discrepancies in terms of dysplasia, cell turnover and diagnosis in patients with multiple potentially malignant oral lesions |
| Q38157868 | Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia? |
| Q38169808 | Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia |
| Q52606072 | Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas. |
| Q34618552 | Colposcopy - a novel diagnostic technique for oral mucosal lesions |
| Q39572493 | Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia |
| Q47912212 | Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions |
| Q50673869 | DNA content as a prognostic marker in patients with oral leukoplakia. |
| Q36038839 | Development and validation of a classification and scoring system for the diagnosis of oral squamous cell carcinomas through confocal laser endomicroscopy |
| Q50065407 | Dysplasia Should Not Be Ignored in Lichenoid Mucositis. |
| Q37769484 | Dysplasia of the upper aerodigestive tract squamous epithelium |
| Q35073530 | Early detection of oral cancer: PAP and AgNOR staining in brush biopsies |
| Q47094554 | Evaluating oral epithelial dysplasia classification system by near-infrared Raman spectroscopy |
| Q43228337 | Evaluation of AgNORs in Oral Potentially Malignant Lesions. |
| Q90608276 | Evaluation of immunohistochemical expression of TWIST in oral epithelial dysplasia and squamous cell carcinoma |
| Q38389703 | Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma |
| Q80458572 | Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions |
| Q35806543 | Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma |
| Q34657641 | Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review. |
| Q41817918 | Grading of oral epithelial dysplasia: Points to ponder |
| Q39759600 | Grading oral epithelial dysplasia: analysis of individual features |
| Q37477400 | Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility |
| Q37406862 | HuR and podoplanin expression is associated with a high risk of malignant transformation in patients with oral preneoplastic lesions |
| Q36034128 | Image Analysis in Surgical Pathology |
| Q36163399 | Image Analysis of the Tumor Microenvironment |
| Q35688177 | Immunohistochemical analysis of oral dysplasia: diagnostic assessment by fascin and podoplanin expression |
| Q36518946 | Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity |
| Q42447434 | Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia |
| Q34810915 | Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies |
| Q38468565 | Improved surgical margin definition by narrow band imaging for resection of oral squamous cell carcinoma: A prospective gene expression profiling study |
| Q49499911 | Inter- and Intra-Observer Variability in Diagnosis of Oral Dysplasia |
| Q41683006 | Inter- and intra-observer variability in three grading systems for oral epithelial dysplasia |
| Q93017331 | Inter-observer Variability in the Diagnosis of Proliferative Verrucous Leukoplakia: Clinical Implications for Oral and Maxillofacial Surgeon Understanding: A Collaborative Pilot Study |
| Q41258593 | Inter-observer agreement in laryngeal pre-neoplastic lesions. |
| Q36042552 | Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials |
| Q24243783 | Interventions for treating oral leukoplakia |
| Q24246650 | Interventions for treating oral leukoplakia |
| Q34535749 | Interventions for treating oral leukoplakia to prevent oral cancer. |
| Q38113233 | Is there any benefit in surgery for potentially malignant disorders of the oral cavity? |
| Q36044929 | MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma. |
| Q33647581 | Management of oral carcinoma: benefits of early precancerous intervention |
| Q36719978 | Management of oral epithelial dysplasia: a review. |
| Q39371584 | Meta-analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders. |
| Q41878623 | Morphometry of the basal cell layer of oral leukoplakia and oral squamous cell carcinoma using computer-aided image analysis |
| Q33785690 | Nano-bio-chip sensor platform for examination of oral exfoliative cytology |
| Q52952843 | Observer agreement in the grading of oral epithelial dysplasia. |
| Q36931001 | Optimizing biomarkers and endpoints in oral cancer chemoprevention trials |
| Q64242260 | Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders |
| Q47845969 | Oral epithelial dysplasia: clinical characteristics of western European residents |
| Q41671855 | Oral leukoplakia: a clinicopathological review |
| Q34776873 | Oral leukoplakia: a proposal for uniform reporting |
| Q41671874 | Oral leukoplakias: to treat or not? |
| Q53590383 | Oral lycopene--an efficacious treatment for oral leukoplakia? |
| Q35092115 | Oral mucosal dysplastic lesions and early squamous cell carcinomas: underdiagnosis from incisional biopsy |
| Q83147162 | Oral premalignant lesions |
| Q37827734 | Oral premalignant lesions: from a clinical perspective |
| Q37828440 | Oral premalignant lesions: from the pathological viewpoint |
| Q41954385 | PCNA and p53 expression in oral leukoplakia with different degrees of keratinization |
| Q47877197 | PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma |
| Q77495031 | Pathology in disgrace? |
| Q53060278 | Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. |
| Q37218761 | Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions |
| Q38183795 | Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory |
| Q40565673 | Potentially malignant oral lesions in Northern Ireland: size (extent) matters |
| Q41978143 | Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis |
| Q35134845 | Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics |
| Q73351332 | Prognostic value of graph theory-based tissue architecture analysis in carcinomas of the tongue |
| Q35106813 | Progress in determining the malignant potential of oral lesions |
| Q33723572 | RETRACTED: Novel management of oral cancer: a paradigm of predictive oncology |
| Q43004550 | Raman difference spectroscopy: a non-invasive method for identification of oral squamous cell carcinoma |
| Q34637914 | Reproducibility of grading systems in oral epithelial dysplasia |
| Q41488818 | Role of brush biopsy and DNA cytometry for prevention, diagnosis, therapy, and followup care of oral cancer |
| Q55260631 | Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. |
| Q35585998 | Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland |
| Q36250713 | TWIST and p-Akt immunoexpression in normal oral epithelium, oral dysplasia and in oral squamous cell carcinoma. |
| Q35963741 | Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities |
| Q37352556 | Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. |
| Q74217955 | The effect of clinical information on the histopathologic diagnosis of oral epithelial dysplasia |
| Q36028406 | The evolution of predictive oncology and molecular-based therapy for oral cancer prevention |
| Q81679258 | The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients |
| Q30669813 | The use of diagnostic data in clinical dental practice |
| Q82086439 | Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study |
| Q56765412 | When is an oral leukoplakia premalignant? |